Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-26-006411
Filing Date
2026-01-07
Accepted
2026-01-07 16:36:02
Documents
2
Period of Report
2026-01-05

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1558
2 EX-24 sabs-ex24.htm EX-24 3953
  Complete submission text file 0001193125-26-006411.txt   7086
Mailing Address C/O CELLDEX THERAPEUTICS, INC 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ 08827
Business Address
Jain Rita (Reporting) CIK: 0001707797 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39871 | Film No.: 26516126

Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)